基本信息
views: 48

Bio
Dr Mohd. Farooq Shaikh is an Associate Professor in Pharmacology. He is actively involved in neuropharmacological research. His personal interest is experimental epilepsy and the discovery of anti-epileptic drugs from diverse sources including medicinal plants. Currently, his team is working on epilepsy and Alzheimer’s disease-related cognitive dysfunctions.
Research Interests
Papers共 193 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Targeted Therapy for the Central Nervous Systempp.27-42, (2025)
Fathima Ijaza Irzan,Thaarvena Retinasamy, Wong Ruo Wen, Edward Ting Ming Sheng,Mohd Farooq Shaikh,Alina Arulsamy
Frontiers in bioscience (Landmark edition)no. 2 (2025): 25544-25544
Irma Wati Ngadimon,Devi Mohan,Mohd Farooq Shaikh,Ching Soong Khoo,Hui Jan Tan, Yu Mey Lee, Nor Syazwani Chamhuri,Farizal Fadzil, Nursyazwana Zolkafli,Alina Arulsamy,Jegan Thanabalan,Angel Aledo-Serrano,Wing Loong Cheong
Epilepsia openno. 2 (2025): 494-507
Journal of neuroscience researchno. 4 (2025): e70033-e70033
Handbook of Neurodegenerative Disorderspp.559-568, (2024)
Frontiers in Bioscience-Landmarkno. 6 (2024): 229-229
Irma Wati Ngadimon,Devi Mohan,Mohd. Farooq Shaikh,Ching Soong Khoo,Hui Jan Tan, Yu Mey Lee, Nor Syazwani Chamhuri,Farizal Fadzil, Nursyazwana Zolkafli,Alina Arulsamy,Jegan Thanabalan,Angel Aledo-Serrano,Wing Loong Cheong
openalex(2024)
FOLIA NEUROPATHOLOGICAno. 3 (2024): 277-292
Enes Akyuz,Alina Arulsamy,Feyza Sule Aslan, Bugra Sarisözen, Beyzanur Guney, Abdulhekim Hekimoglu,Beyza Nur Yilmaz,Thaarvena Retinasamy,Mohd. Farooq Shaikh
Molecular neurobiologyno. 2 (2024): 1631-1674
Load More
Author Statistics
#Papers: 193
#Citation: 2639
H-Index: 27
G-Index: 46
Sociability: 6
Diversity: 3
Activity: 68
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn